Simon Erridge is the Research Director of Curaleaf, a clinic that helps eligible patients with affordable *plant medicine care. In this episode, we explore the story behind the business that can’t say what they sell. We discuss exclusive patient experiences, the limitations this medicine receives from UK regulations as well as the future of the medication. Could your business thrive through only word-of-mouth? What are the challenges the clinic face? What education does Curaleaf bring to doctors and law enforcers? Find out more in this one-of-a-kind episode! Connect with Simon - https://www.linkedin.com/in/simon-erridge/ Become a CX Insider - https://www.linkedin.com/company/cx-insider/ Check out our website - https://cxinsider.com/ Thank you to our sponsor! - https://www.acftechnologies.com/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related